News Image

HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone

Provided By GlobeNewswire

Last update: May 29, 2025

Southlake, TX, May 29, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to enable earlier detection of heart disease, today announced the signing of its first commercial customer for the MyoVista Insights™ platform: Westcliffe Health Innovations, based in the United Kingdom.

Read more at globenewswire.com

HEART TEST LABORATORIES-CW27

NASDAQ:HSCSW (6/13/2025, 8:07:27 PM)

0.14

+0.09 (+167.69%)


HEARTSCIENCES INC

NASDAQ:HSCS (6/13/2025, 8:07:27 PM)

After market: 3.51 -0.06 (-1.77%)

3.5734

-0.03 (-0.74%)



Find more stocks in the Stock Screener

Follow ChartMill for more